AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 267 filers reported holding AVANOS MED INC in Q3 2021. The put-call ratio across all filers is 3.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $590 | -24.7% | 29,184 | -5.0% | 0.01% | -22.2% |
Q2 2023 | $784 | -17.1% | 30,706 | -3.6% | 0.01% | -18.2% |
Q1 2023 | $946 | +8.0% | 31,841 | -1.7% | 0.01% | 0.0% |
Q4 2022 | $876 | -99.9% | 32,378 | +0.6% | 0.01% | +22.2% |
Q3 2022 | $700,000 | -28.4% | 32,184 | -10.1% | 0.01% | -25.0% |
Q2 2022 | $978,000 | -12.8% | 35,795 | +6.8% | 0.01% | 0.0% |
Q1 2022 | $1,122,000 | -5.1% | 33,520 | -1.8% | 0.01% | +9.1% |
Q4 2021 | $1,182,000 | +7.9% | 34,120 | -2.8% | 0.01% | 0.0% |
Q3 2021 | $1,095,000 | -9.5% | 35,105 | +5.5% | 0.01% | -8.3% |
Q2 2021 | $1,210,000 | +268.9% | 33,280 | +342.8% | 0.01% | +200.0% |
Q1 2021 | $328,000 | -7.9% | 7,515 | -3.3% | 0.00% | 0.0% |
Q4 2020 | $356,000 | +31.4% | 7,772 | -4.8% | 0.00% | +33.3% |
Q3 2020 | $271,000 | +8.8% | 8,161 | -3.9% | 0.00% | 0.0% |
Q2 2020 | $249,000 | +12.7% | 8,494 | +3.1% | 0.00% | 0.0% |
Q1 2020 | $221,000 | -16.6% | 8,242 | +4.6% | 0.00% | 0.0% |
Q4 2019 | $265,000 | -16.4% | 7,879 | -7.1% | 0.00% | -25.0% |
Q3 2019 | $317,000 | – | 8,479 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
S.A. Mason LLC | 6,527 | $299,000 | 0.25% |